PortfoliosLab logoPortfoliosLab logo
WBIY vs. GERM
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

WBIY vs. GERM - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in WBI Power Factor High Dividend ETF (WBIY) and Amplify Treatments, Testing and Advancements ETF (GERM). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period


WBIY

1D
0.69%
1M
2.63%
YTD
10.76%
6M
11.81%
1Y
27.44%
3Y*
17.19%
5Y*
9.29%
10Y*

GERM

1D
0.00%
1M
0.00%
YTD
0.00%
6M
0.00%
1Y
0.00%
3Y*
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

WBIY vs. GERM - Yearly Performance Comparison


2026 (YTD)20252024
WBIY
WBI Power Factor High Dividend ETF
10.76%13.00%0.20%
GERM
Amplify Treatments, Testing and Advancements ETF
0.00%0.00%0.00%

WBIY vs. GERM - Sectors Allocation Comparison


Sectors
WBIY
GERM

Financial Services

18.7%
0.4%

Consumer Defensive

16.4%

-

Consumer Cyclical

13.1%

-

Communication Services

11.0%

-

Technology

10.1%

-

Industrials

9.4%

-

Healthcare

6.2%
99.3%

Utilities

6.1%

-

Energy

6.0%

-

Basic Materials

1.9%

-

Real Estate

1.1%

-

Financial Services

WBIY
18.7%
GERM
0.4%

Consumer Defensive

WBIY
16.4%
GERM

-

Consumer Cyclical

WBIY
13.1%
GERM

-

Communication Services

WBIY
11.0%
GERM

-

Technology

WBIY
10.1%
GERM

-

Industrials

WBIY
9.4%
GERM

-

Healthcare

WBIY
6.2%
GERM
99.3%

Utilities

WBIY
6.1%
GERM

-

Energy

WBIY
6.0%
GERM

-

Basic Materials

WBIY
1.9%
GERM

-

Real Estate

WBIY
1.1%
GERM

-

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

WBIY vs. GERM — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

WBIY
WBIY Risk / Return Rank: 6262
Overall Rank
WBIY Sharpe Ratio Rank: 5454
Sharpe Ratio Rank
WBIY Sortino Ratio Rank: 6262
Sortino Ratio Rank
WBIY Omega Ratio Rank: 5353
Omega Ratio Rank
WBIY Calmar Ratio Rank: 8181
Calmar Ratio Rank
WBIY Martin Ratio Rank: 6060
Martin Ratio Rank

GERM
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

WBIY vs. GERM - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for WBI Power Factor High Dividend ETF (WBIY) and Amplify Treatments, Testing and Advancements ETF (GERM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


WBIYGERMDifference
Sharpe ratioReturn per unit of total volatility

Sortino ratioReturn per unit of downside risk

Omega ratioGain probability vs. loss probability

1.33

Calmar ratioReturn relative to maximum drawdown

4.16

Martin ratioReturn relative to average drawdown

10.49

WBIY vs. GERM - Sharpe Ratio Comparison


Loading charts...

Sharpe Ratios by Period


WBIYGERMDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.83

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.50

Sharpe Ratio (All Time)

Calculated using the full available price history

0.38

Drawdowns

WBIY vs. GERM - Drawdown Comparison

The maximum WBIY drawdown since its inception was -48.71%, which is greater than GERM's maximum drawdown of 0.00%. Use the drawdown chart below to compare losses from any high point for WBIY and GERM.


Loading charts...

Drawdown Indicators


WBIYGERMDifference

Max Drawdown

Largest peak-to-trough decline

-48.71%

0.00%

-48.71%

Max Drawdown (1Y)

Largest decline over 1 year

-6.63%

0.00%

-6.63%

Max Drawdown (3Y)

Largest decline over 3 years

-19.37%

Max Drawdown (5Y)

Largest decline over 5 years

-20.97%

Current Drawdown

Current decline from peak

-1.15%

0.00%

-1.15%

Average Drawdown

Average peak-to-trough decline

-7.11%

0.00%

-7.11%

Ulcer Index

Depth and duration of drawdowns from previous peaks

2.62%

0.00%

+2.62%

Volatility

WBIY vs. GERM - Volatility Comparison

WBI Power Factor High Dividend ETF (WBIY) has a higher volatility of 3.67% compared to Amplify Treatments, Testing and Advancements ETF (GERM) at 0.00%. This indicates that WBIY's price experiences larger fluctuations and is considered to be riskier than GERM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


WBIYGERMDifference

Volatility (1M)

Calculated over the trailing 1-month period

3.67%

0.00%

+3.67%

Volatility (6M)

Calculated over the trailing 6-month period

8.92%

0.00%

+8.92%

Volatility (1Y)

Calculated over the trailing 1-year period

15.07%

0.00%

+15.07%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

18.51%

0.00%

+18.51%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

22.65%

0.00%

+22.65%

WBIY vs. GERM - Expense Ratio Comparison

WBIY has a 0.97% expense ratio, which is higher than GERM's 0.68% expense ratio.


Dividends

WBIY vs. GERM - Dividend Comparison

WBIY's dividend yield for the trailing twelve months is around 4.38%, while GERM has not paid dividends to shareholders.


PositionTTM2025202420232022202120202019201820172016
GERM
Amplify Treatments, Testing and Advancements ETF
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
WBIY
WBI Power Factor High Dividend ETF
4.38%4.73%4.57%4.87%4.40%3.94%5.10%4.54%3.25%5.84%0.01%

Frequently Asked Questions


WBIY has higher volatility (3.67%) compared to GERM (0.00%). In terms of maximum drawdown, WBIY dropped -48.71% vs GERM's 0.00%.

On 1-year performance, WBIY leads with 27.44% vs 0.00% for GERM. On fees, GERM is cheaper at 0.68% per year. On volatility, GERM has been the lower-risk option at 0.00%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 1-year period, WBIY has performed better with a 27.44% return vs 0.00%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

GERM is cheaper with a 0.68% expense ratio, compared with 0.97% for WBIY.

WBIY has the higher dividend yield at 4.38%, compared with 0.00% for GERM.

WBIY is categorized as Mid Cap Value Equities, while GERM is Health & Biotech Equities. WBIY tracks Solactive Power Factor High Dividend Index, while GERM tracks Prime Treatments, Testing and Advancements Index. They also come from different issuers: WBI and Amplify. Their fees differ too: 0.97% for WBIY and 0.68% for GERM.

Portfolio Optimizer

Find the right allocation for WBIY and GERM

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer